3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Leukemia, Myeloid, Acute
2
HIV Infections
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Anus Neoplasms
2
Solitary Fibrous Tumor, Pleural
1
Smoldering Multiple Myeloma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostate Adenocarcinoma
1
Precancerous Conditions
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liposarcoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leiomyosarcoma
1
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
Watchful Waiting
×
Clear all
No trials found.